CKMB Antibody(Affinity Pure)

Product Description

CKMB Antibody
Catalog number: B2010227
Lot number: Batch Dependent
Expiration Date: Batch dependent
Volume/Weight: 0.5 mg
Supplied as: Ready-to-use
Appearance: Solution
Applications: high specificity antibody to creatine kinase MB (CKMB).
Storage: -20C
Keywords: CKMB antibodies, CK-MB antibodies, creatine kinase MB antibodies
Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um.

References:
1: Athamneh H, Basnawi A, Siler-Fisher A. CKMB and acute myocardial infarction
in the emergency department. J Emerg Med. 2013 Oct;45(4):617-8.

2: Song Y, Zhong J, Zhao L, Shaoji T. Determination of CKMB activity and protein
concentration and their application in the diagnosis of AMI. J Tongji Med Univ.
2000;20(4):301-2.

3: Sellgren A, Nilsson F, Jeppsson A. The relationship between ASAT, CKMB,
troponin-T and mortality after cardiac surgery. Scand Cardiovasc J. 2007
Dec;41(6):386-90.
4: Ndrepepa G, Kastrati A. Creatine kinase myocardial band – a biomarker to
assess prognostically relevant periprocedural myocardial infarction. Int J
Cardiol. 2018 Nov 1;270:118-119.

5: Fan J, Ma J, Xia N, Sun L, Li B, Liu H. Clinical Value of Combined Detection
of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial
Infarction. Clin Lab. 2017 Mar 1;63(3):427-433.

6: Boumans ML, Diris JH, Nap M, Muijtjens AM, Maessen JG, van Dieijen-Visser MP,
Hermens WT. Creatine kinase isoenzyme MB (CKMB) controversy: perimortal tissue
acidosis may explain the absence of CKMB in myocardium at autopsy. Clin Chem.
2001 Sep;47(9):1733-5.

7: Schulenburg D, De Lange W, Van Jaarsveld H, Kuyl JM. Persistently elevated
CKMB and negative troponin T in a patient at ischaemic risk with chest pain.
Cardiovasc J Afr. 2010 Jan-Feb;21(1):47-8.

8: Kavsak PA, MacRae AR, Newman AM, Lustig V, Palomaki GE, Ko DT, Tu JV, Jaffe
AS. Effects of contemporary troponin assay sensitivity on the utility of the
early markers myoglobin and CKMB isoforms in evaluating patients with possible
acute myocardial infarction. Clin Chim Acta. 2007 May 1;380(1-2):213-6.

9: Ma Y, Xiang C, Zhang B. Efficacy Evaluation of High-Dose Atorvastatin
Pretreatment in Patients with Acute Coronary Syndrome: A Meta-Analysis of
Randomized Controlled Trials. Med Sci Monit. 2018 Dec 23;24:9354-9363.

10: Ahmed OE, Abohamr SI, Alharbi SA, Aldrewesh DA, Allihimy AS, Alkuraydis SA,
Alhammad IM, Elsheikh E, Azazy AS, Mohammed AA, Dar MA, Abazid RM. In-hospital
mortality of acute coronary syndrome in elderly patients. Saudi Med J. 2019
Oct;40(10):1003-1007.

11: Hong F, Song L, Zhu YY, Ji JH, Zhu MJ, Xu M. Cardiac troponin I, myoglobin,
and creatine kinase-Mb as new biomarkers for diagnosis of neonatal hypoxic
ischemic encephalopathy. J Biol Regul Homeost Agents. 2019 Jul-
Aug;33(4):1201-1207.

12: Oriyanhan W, Miyamoto TA, Yamazaki K, Miwa S, Takaba K, Ikeda T, Komeda M.
Regionally perfused taurine. Part I. Minimizes lactic acidosis and preserves
CKMB and myocardial contractility after ischemia/reperfusion. Adv Exp Med Biol.
2006;583:271-88.

Products Related to CKMB Antibody: Antibodies